कोशिश गोल्ड - मुक्त
Intas Pharma bags another overseas co
Mint New Delhi
|January 08, 2025
Gujarat-based drug-maker Intas Pharmaceuticals Ltd, which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.
Intas Pharma has agreed to buy Udenyca brand through its US specialty division, Accord BioPharma, for up to $558.4 million (nearly ₹4,800 crore), according to a press release.
Udenyca is the brand name for medication pegfilgrastim-cbqv, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications.
यह कहानी Mint New Delhi के January 08, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint New Delhi से और कहानियाँ
Mint New Delhi
Sebi may reduce non-expiry day margins for long-term F&O boost
Sebi is considering reducing the ELM from 2% to 0.5-1% on non-expiry days only for a hedged portfolio, with an unhedged portfolio attracting the normal 2% ELM.
1 mins
December 15, 2025
Mint New Delhi
Arcelor Mittal-Nippon JV to grow 3x by 2030
Planned investments of ₹60,000 crore underscores its expansion strategy
2 mins
December 15, 2025
Mint New Delhi
Govt tightens pollution curbs in New Delhi, halts construction
India stepped up antipollution curbs in New Delhi and nearby areas after a sudden spike in airborne toxins.
1 min
December 15, 2025
Mint New Delhi
A Lok Sabha MP was caught vaping in Parliament. Is it legal to do so?
A complaint lodged in the Lok Sabha has brought Indian laws around vaping into focus.
2 mins
December 15, 2025
Mint New Delhi
Pulses being wasted due to unsafe storage
A government-commissioned study on India’s pulses stocks shows serious gaps in storage practices, raising concern over availability of a key protein source for millions of Indians.
1 min
December 15, 2025
Mint New Delhi
Nov gems, jewellery exports climb 20%
India’s gems and jewellery exports grew 19.64% to $2.5 billion in November compared to the same month last year, according to the Gem and Jewellery Export Promotion Council (GJEPC).
1 min
December 15, 2025
Mint New Delhi
‘Avoid cos where promoters pull cash amid capital needs’
Kela’s remarks come at a time when IPOs in 2025 are dominated by offer-for-sale issues
2 mins
December 15, 2025
Mint New Delhi
Uncrewed Gaganyaan, six more missions by Mar: Isro
Indian Space Research Organisation (Isro) has lined up seven launch missions by March next year, including one to demonstrate home-built electric propulsion systems for satellite and quantum key distribution technologies, and the first uncrewed mission of the Gaganyaan project.
1 mins
December 15, 2025
Mint New Delhi
'India champion for tax transparency'
India is a “strong champion” in implementing transparency measures against offshore tax evasion and its recent campaign asking taxpayers to correctly report their undisclosed foreign assets has led to disclosure of properties worth more than ₹29,000 crore, a top official of the Organisation for Economic Cooperation and Development (OECD) said.
1 min
December 15, 2025
Mint New Delhi
Acko plans IPO of up to $400 mn to join a wave of listings
India’s IPO market saw firms
1 mins
December 15, 2025
Listen
Translate
Change font size